Home » Topics » BioWorld Science

BioWorld Science
RSS

New phase II trial explores voclosporin ophthalmic solution for dry eye syndrome

July 12, 2018

Pivotal study of KP-415 in children with ADHD meets primary efficacy endpoint

July 12, 2018

Galapagos, AbbVie discover CFTR modulators

July 12, 2018

National Center for Global Health and Medicine, Kumamoto University and Yamasa patent antivirals

July 12, 2018

Amgen describes new beta-secretase inhibitors

July 12, 2018

OG-716, a lantibiotic that is active against Clostridium difficile infections

July 12, 2018

Argenx presents phase II data for ARGX-113 in myasthenia gravis

July 12, 2018

Advaxis withdraws conditional MAA for axalimogene filolisbac, advances ADXS-HOT program

July 12, 2018

Recursion set to begin phase I study of AI/ML-based drug candidate, REC-994

July 12, 2018

First patient dosed in phase II study of CV-301 plus nivolumab in metastatic colorectal cancer

July 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...